Induction of tau pathology by intracerebral infusion of amyloid-beta -containing brain extract and by amyloid-beta deposition in APP x Tau transgenic mice
about
Infectivity versus Seeding in Neurodegenerative Diseases Sharing a Prion-Like MechanismEvidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathyTransmission and spreading of tauopathy in transgenic mouse brainInsights into Mechanisms of Chronic NeurodegenerationTau Oligomers: The Toxic Player at Synapses in Alzheimer's DiseaseBody fluid biomarkers in Alzheimer's diseasePathogenic protein seeding in Alzheimer disease and other neurodegenerative disordersEmerging roles of exosomes in normal and pathological conditions: new insights for diagnosis and therapeutic applicationsModeling Alzheimer's disease in mouse without mutant protein overexpression: cooperative and independent effects of Aβ and tauNonhuman primate models of Alzheimer-like cerebral proteopathyAnimal models for Alzheimer's disease and frontotemporal dementia: a perspectiveTau pathology induces loss of GABAergic interneurons leading to altered synaptic plasticity and behavioral impairments.Modeling familial Danish dementia in mice supports the concept of the amyloid hypothesis of Alzheimer's disease.Convergence of amyloid-beta and tau pathologies on mitochondria in vivo.Is there a risk of prion-like disease transmission by Alzheimer- or Parkinson-associated protein particles?Probing the biology of Alzheimer's disease in mice.Aβ1-42 monomers or oligomers have different effects on autophagy and apoptosisAntioxidants have a rapid and long-lasting effect on neuritic abnormalities in APP:PS1 mice.Design of small molecules that target metal-A{beta} species and regulate metal-induced A{beta} aggregation and neurotoxicity.Tau, prions and Aβ: the triad of neurodegeneration.Models of β-amyloid induced Tau-pathology: the long and "folded" road to understand the mechanism.Tau aggregation and its interplay with amyloid-β.Atherosclerosis and Alzheimer--diseases with a common cause? Inflammation, oxysterols, vasculatureAmyloid accelerates tau propagation and toxicity in a model of early Alzheimer's diseaseAbnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's diseaseModes of Aβ toxicity in Alzheimer's disease.Mitochondrial dysfunction - the beginning of the end in Alzheimer's disease? Separate and synergistic modes of tau and amyloid-β toxicityRac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer's disease.Humanized Tau Mice with Regionalized Amyloid Exhibit Behavioral Deficits but No Pathological Interaction.Trans-cellular propagation of Tau aggregation by fibrillar speciesDeficiency of terminal complement pathway inhibitor promotes neuronal tau pathology and degeneration in mice.Can infections cause Alzheimer's disease?Heterotypic seeding of Tau fibrillization by pre-aggregated Abeta provides potent seeds for prion-like seeding and propagation of Tau-pathology in vivo.Advances in the pathogenesis of Alzheimer's disease: focusing on tau-mediated neurodegeneration.Tau imaging in neurodegenerative diseases.Amyloid plaque and neurofibrillary tangle pathology in a regulatable mouse model of Alzheimer's disease.Brain homogenates from human tauopathies induce tau inclusions in mouse brainβ-Amyloid oligomers in aging and Alzheimer's disease.Neuroprotective effects of D-Ala(2)GIP on Alzheimer's disease biomarkers in an APP/PS1 mouse model.APP/PS1 mice overexpressing SREBP-2 exhibit combined Aβ accumulation and tau pathology underlying Alzheimer's disease.
P2860
Q21284823-1E461C3B-2C5B-45D2-8955-22589B549752Q22251077-E6340515-EA56-472D-A949-2227DF3B7683Q24651334-9BA7E8C7-BA2A-497B-8468-AC03907513A7Q26771732-AC763486-C90A-4F81-B111-00FA8A9C9B36Q26773154-2E700768-2A3A-46A8-BB32-5B03AAD507BDQ26830098-DAF37582-CF95-4355-A2FC-911DB5521734Q26850298-F2BA290E-671A-4825-93D4-758AF07E2393Q28081849-A63C0350-D0B3-4553-9E83-EE20895ED402Q28535293-EA5030B9-4687-4C0C-91AB-0B3D37813647Q28728135-25763C4D-843F-4897-B16F-9F4FE40165FDQ28749702-D13DC5EC-174E-4968-8289-259D5ED2D1AFQ30444295-E956DE1F-92C1-4D60-A1A2-FB6FC6A0141EQ33842635-4AD0E27B-A9E0-4A33-9743-1017CD319166Q33876147-04ED24FE-58EA-498B-BC28-503EA3AEAD5FQ34157427-F4B96076-8185-406A-8551-037633BFF214Q34206962-2FEA3907-EC03-40A9-AE18-93842A69CDFFQ34344718-9FA8BA7C-54B4-441F-9DAA-A7C200C6FC87Q34374743-C4C69BE4-7424-4CC4-B22F-B8912D15BBF4Q34438376-287F1CFA-06B1-4B0E-9B05-AC3FA553092DQ34463061-99ED3D00-518B-4BC2-A288-D3D85C0D83A7Q34631209-A8679F82-514F-46BF-AEED-D740B97852F5Q35008256-27AC1147-F9F8-4E86-88DF-0A87882015A9Q35127516-6965CB06-8D8B-4336-B4F9-3F395279F203Q35212180-298F202E-A969-4E6E-A2B1-EFBA730D5DD7Q35223831-9C09E335-3539-42F4-B818-9400A5093442Q35235869-BE1469BC-CAC2-4C3C-89F5-B11BCD0573ECQ35579318-D7B00629-7481-410C-9171-D2688AA2AF61Q35951970-16EE637F-8496-47B5-9162-E7056A82CE67Q35986968-54A2E59E-7D0F-4348-8A39-B1F56CC1ACEFQ36003836-696367A6-BF78-44F5-9DFF-60DA020A01F6Q36437437-09F5CA8A-17C1-4AC7-9C92-5B76680CEA0DQ36449877-631DEC20-8505-450D-BD80-3CCDF303CFB1Q36680395-5049AF30-19E0-451D-93BD-427187EB3C27Q36688393-C3B9276B-4F6A-4D18-B4A4-3573CDA86103Q36834567-317CD0C7-CEA6-4EBE-B8DF-7DBD40EAA92BQ36855702-E2B97DDA-1A84-474E-AE00-440175B042BFQ36915421-E93FD187-7B3A-419E-9F66-95E8C178846FQ36981528-28D693CB-899C-4C63-BE88-10F4E05F2071Q36997912-C1663CC0-08BC-4D5D-B013-55412F2E2B1EQ37078850-6464979F-ADE9-4D5B-97BE-B7BB441C27D4
P2860
Induction of tau pathology by intracerebral infusion of amyloid-beta -containing brain extract and by amyloid-beta deposition in APP x Tau transgenic mice
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Induction of tau pathology by ...... n in APP x Tau transgenic mice
@ast
Induction of tau pathology by ...... n in APP x Tau transgenic mice
@en
Induction of tau pathology by ...... n in APP x Tau transgenic mice
@nl
type
label
Induction of tau pathology by ...... n in APP x Tau transgenic mice
@ast
Induction of tau pathology by ...... n in APP x Tau transgenic mice
@en
Induction of tau pathology by ...... n in APP x Tau transgenic mice
@nl
prefLabel
Induction of tau pathology by ...... n in APP x Tau transgenic mice
@ast
Induction of tau pathology by ...... n in APP x Tau transgenic mice
@en
Induction of tau pathology by ...... n in APP x Tau transgenic mice
@nl
P2093
P2860
P50
P3181
P1476
Induction of tau pathology by ...... n in APP x Tau transgenic mice
@en
P2093
Florence Clavaguera
Jada Lewis
Markus Tolnay
Mike Hutton
Rebecca Radde
Tristan Bolmont
P2860
P304
P3181
P356
10.2353/AJPATH.2007.070403
P407
P577
2007-12-01T00:00:00Z